Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Norris

Showing results (471-480 of 531) with videos related to

Pageof 54
Sort By:
Leukemia|April 25, 2021
Combination efficacy of ruxolitinib with standard-of-care drugs in CRLF2-rearranged Ph-like acute lymphoblastic leukemiaJulia W Bӧhm, Keith C S Sia, Connor Jones, et al.
Molecular Oncology|February 21, 2025
The polyamine transporter ATP13A3 mediates difluoromethylornithine-induced polyamine uptake in neuroblastomaMujahid Azfar, Weiman Gao, Chris Van den Haute, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 26, 2016
Polyamine Antagonist Therapies Inhibit Neuroblastoma Initiation and ProgressionNicholas F Evageliou, Michelle Haber, Annette Vu, et al.
Journal of Experimental & Clinical Cancer Research : CR|August 14, 2025
Arginine depletion potentiates standard-of-care chemo-immunotherapy in preclinical models of high-risk neuroblastomaKimberley M Hanssen, Jayne Murray, Ruby Pandher, et al.
British Journal of Haematology|December 2, 2017
A risk score including microdeletions improves relapse prediction for standard and medium risk precursor B-cell acute lymphoblastic leukaemia in childrenRosemary Sutton, Nicola C Venn, Tamara Law, et al.
Journal of Molecular Medicine (Berlin, Germany)|February 13, 2024
FDA-approved disulfiram as a novel treatment for aggressive leukemiaMawar Karsa, Lin Xiao, Emma Ronca, et al.
British Journal of Haematology|June 5, 2026
BCL-2 and MCL1 co-inhibition enhances glucocorticoid therapy in preclinical models of infant KMT2A-rearranged acute lymphoblastic leukaemiaMawar Karsa, Ayu Karsa, Dayna Spurling, et al.
Journal of Medicinal Chemistry|March 16, 2017
Discovery of an Acrylic Acid Based Tetrahydroisoquinoline as an Orally Bioavailable Selective Estrogen Receptor Degrader for ERα+ Breast CancerHeather E Burks, Tinya Abrams, Christina A Kirby, et al.
The Journal of Clinical Investigation|May 3, 2017
Androgen receptor antagonism drives cytochrome P450 17A1 inhibitor efficacy in prostate cancerJohn D Norris, Stephanie J Ellison, Jennifer G Baker, et al.
Biochemical Pharmacology|June 29, 2014
High-throughput screening identifies Ceefourin 1 and Ceefourin 2 as highly selective inhibitors of multidrug resistance protein 4 (MRP4)Leanna Cheung, Claudia L Flemming, Fujiko Watt, et al.
Pageof 54

Showing results (471-480 of 531) with videos related to

Sort By:
Pageof 54
Leukemia|April 25, 2021
Combination efficacy of ruxolitinib with standard-of-care drugs in CRLF2-rearranged Ph-like acute lymphoblastic leukemiaJulia W Bӧhm, Keith C S Sia, Connor Jones, et al.
Molecular Oncology|February 21, 2025
The polyamine transporter ATP13A3 mediates difluoromethylornithine-induced polyamine uptake in neuroblastomaMujahid Azfar, Weiman Gao, Chris Van den Haute, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 26, 2016
Polyamine Antagonist Therapies Inhibit Neuroblastoma Initiation and ProgressionNicholas F Evageliou, Michelle Haber, Annette Vu, et al.
Journal of Experimental & Clinical Cancer Research : CR|August 14, 2025
Arginine depletion potentiates standard-of-care chemo-immunotherapy in preclinical models of high-risk neuroblastomaKimberley M Hanssen, Jayne Murray, Ruby Pandher, et al.
British Journal of Haematology|December 2, 2017
A risk score including microdeletions improves relapse prediction for standard and medium risk precursor B-cell acute lymphoblastic leukaemia in childrenRosemary Sutton, Nicola C Venn, Tamara Law, et al.
Journal of Molecular Medicine (Berlin, Germany)|February 13, 2024
FDA-approved disulfiram as a novel treatment for aggressive leukemiaMawar Karsa, Lin Xiao, Emma Ronca, et al.
British Journal of Haematology|June 5, 2026
BCL-2 and MCL1 co-inhibition enhances glucocorticoid therapy in preclinical models of infant KMT2A-rearranged acute lymphoblastic leukaemiaMawar Karsa, Ayu Karsa, Dayna Spurling, et al.
Journal of Medicinal Chemistry|March 16, 2017
Discovery of an Acrylic Acid Based Tetrahydroisoquinoline as an Orally Bioavailable Selective Estrogen Receptor Degrader for ERα+ Breast CancerHeather E Burks, Tinya Abrams, Christina A Kirby, et al.
The Journal of Clinical Investigation|May 3, 2017
Androgen receptor antagonism drives cytochrome P450 17A1 inhibitor efficacy in prostate cancerJohn D Norris, Stephanie J Ellison, Jennifer G Baker, et al.
Biochemical Pharmacology|June 29, 2014
High-throughput screening identifies Ceefourin 1 and Ceefourin 2 as highly selective inhibitors of multidrug resistance protein 4 (MRP4)Leanna Cheung, Claudia L Flemming, Fujiko Watt, et al.
Pageof 54